Research Interests
mental disorders/psychiatry/ps
,
radiology/imaging
,
sleep research
Recent Publications
McDonald WM, McCall WV, Reynolds C, Buysse DJ.
Recognizing sleep disorders and their treatments in geriatric psychiatry [abstract]. Am J Geriatr Psychiatry.
2012;
20(3 Suppl 1):S37.
.
A new method of dynamic, relational, electroencephalic auditory feedback for primary insomnia [abstract]. Sleep.
2012;
35(Abstract Suppl):A220.
McCall W, Gonzales C, Shannon W, Deych E, Farris S, Xian H.
Age-related effects on circadian phase in the sleep of depressed insomniacs [abstract]. Sleep.
2012;
35(Abstract Suppl):A242.
Derreberry T, McDonough A, Batson N, Webster M, Joshi I, Farris S, Garza G, Boggs N, Ahmed M, McCall W.
A theorectical model for understanding how insomnia is a risk factor for suicidal ideation [abstract]. Sleep.
2012;
35(Abstract Suppl):A326.
Brashear A, Hill DF, Boggs N, Ozelius L, Sweadner KJ, Light L, Stacy M, Snively BM, McCall WV.
Psychosis: part of the rapid-onset dystonia-Parkinsonism (RDP) phenotype? [abstract]. Neurology.
2011;
76(9 Suppl 4):A640.
Rosenquist PB, Krystal A, Heart KL, Demitrack M, McCall WV.
Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): effect on sleep in patients with pharmacoresistant major depressive disorder [abstract]. J ECT.
2011;
27(2):179.
McCall WV, Blocker J, Dagostino R Jr, [sic] [D'Agostino R Jr], Wang J, Shannon W.
Both actigraphy data and the intensity of insomnia complaints differ between suicidal and non-suicidal depressed patients enrolled in a hypnotic clinical trial [abstract]. J Sleep Res.
2011;
20(Suppl 1):24.
McCall C, Bowes RC, McCall W.
Objective vs. subjective measurements of sleep in depressed insomniacs: first night effect or reverse first night effect? [abstract]. Sleep.
2011;
34(Suppl):A255-A256.
McCall W, Wang J, Shannon B.
Functional data analysis of actigraphy reveals that SSI and ISI impact night activity [abstract]. Sleep.
2011;
34(Suppl):A332.
Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep.
2010;
33(2):225-234.
Rosenquist PB, Cai H, Greenwald S, McCall WV.
Interictal changes during ECT: use of a frontal quantitative EEG antidepressant treatment response index [abstract]. J ECT.
2010;
26(2):154.
McCall WV, Blocker JN, D'Agostino R Jr, Kimball J, Boggs N, Lasater B, Haskett R, Krystal A, McDonald WM, Rosenquist PB.
Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med.
2010;
6(4):322-329.
Francis A, Fink M, Appiani F, Bertelsen A, Bolwig TG, Braunig P, Caroff SN, Carroll BT, Cavanna AE, McCall WV, et al.
Catatonia in Diagnostic and Statistical Manual of Mental Disorders, fifth edition [editorial]. J ECT.
2010;
26(4):246-247.
Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, et al.
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul.
2010;
3(4):187-199.
McCall W, Blocker JN, D'Agostino R, Kimball J, Boggs N, Lasater B, Rosenquist PB.
Insomnia predicts suidical ideation during a depression clinical trial [abstract]. Sleep.
2010;
33(Abstract Suppl):A247.
Brenes GA, Miller ME, Stanley MA, Williamson JD, Knudson M, McCall V.
Insomnia in older adults with generalized anxiety disorder [abstract]. Am J Geriatr Psychiatry.
2009;
17(3 Suppl 1):A57.
Reifler BV, Smith ML, Beard-Byrd KL, Albert AD, Legault C, McCall WV, Singleton AH, Brenes GA, Johnston DM.
The Wake Forest Geriatric Outreach (GO) Program: the first 100 cases [abstract]. Am J Geriatr Psychiatry.
2009;
17(3 Suppl 1):A80.
Hermida A, Husain M, McCall WV, McDonald WM, Petrides G.
Electroconvulsive therapy: an update on the use of modern ECT techniques and new research findings [abstract]. Am J Geriatr Psychiatry.
2009;
17(3 Suppl 1):A13.
McCall WV.
Stimulus dosing. In: Swartz C, ed. Electroconvulsive and neuromodulation therapies.
New York: Cambridge University Press;
2009:
447-467.
Liguori A, Roth AJ, McCall WV.
Next-day trazodone impairment of arm strength and memory in insomniacs [abstract]. Sleep.
2009;
32(Abstr Suppl):A421.
McCall WV, D'Agostino RB, Kimball JN, Boggs N, Lasater B, Dunn A, Haskett RF, McDonald WM, Krystal A, Rosenquist PB.
Eszopiclone at bedtime improves the quality of life in depressed insomniacs receiving fluoxetene [abstract]. Sleep.
2009;
32(Abstr Suppl):A348-A349.
Morin C, Krystal A, McCall V, Schaefer K, Claus R, Wilson A, Friedman M, Roth T, Ancoli-Israel S.
A responder analysis using the insomnia severity index in older adults treated for 12 weeks with eszopiclone 2mg or placebo [abstract]. Sleep.
2009;
32(Abstr Suppl):A266-A267.
Schwartz JR, Khan A, McCall V, Weintraub J, Tiller J.
A 12 month or more open-label study of the efficacy and tolerability of armodafinil [abstract]. Sleep.
2009;
32(Abstr Suppl):A50-A51.
McDonald WM, Meeks TW, McCall WV, Zorumski CF.
Electroconvulsive therapy. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing textbook of psychopharmacology. 4th ed.
Washington (DC): American Psychiatric Publishing;
2009:
861-899.
Williams J, Ikwechegh O, McCall WV, Kimball J, Rosenquist P.
Patients' same day recall of ECT procedures [abstract]. J ECT.
2009;
25(2):148.
Shin HW, O'Donovan CA, Grefe A, McCall WV, Boggs JG, Harper A, Bell WL, Rosenquist P.
Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient [abstract]. Epilepsia.
2009;
50(Suppl 11):133-134.
Rosenquist PB, Andrade C, Williams J, Ikwechegh O, Kimball J, Arias L, McCall WV.
Electroconvulsive therapy (ECT) associated awareness under anesthesia and spontaneous recall [abstract]. J Neuropsychiatry Clin Neurosci.
2009;
21(2):9.
McCall WV, Dillingham E, Haskett RF, Prudic J, Isenberg K, Sackeim HA.
Concomitant antidepressant medication during ECT does not prevent early post-ECT relapse [abstract]. J ECT.
2008;
24(1):103.
Brenes GA, Knudson M, McCall V, Williamson J, Miller M, Stanley MA.
Age and racial differences in the presentation and treatment of generalized anxiety disorder in primary care [abstract]. Am J Geriatr Psychiatry.
2008;
16(3 Suppl 1):A88-A89.
Roth T, McCall WV, McCurry S.
Uncovering the link: psychiatric and sleep disturbances in older adults [abstract]. Am J Geriatr Psychiatry.
2008;
16(3 Suppl 1):A25.
McCall WV, Kimball J, Boggs N, Lasater B, Rosenquist PB.
Correlation between polysomnography and actigraphy in detecting change in macro sleep variables during treatment of persons with both depression and imsomnia [abstract]. Sleep.
2008;
31(Abstr Suppl):A335-A336.
McCall WV, Kimball J, Boggs N, Lasater B, Rosenquist PB.
Actigraphy as a component of screening for sleep apnea and periodic limb movements [abstract]. Sleep.
2008;
31(Abstr Suppl):A336.
Fava M, Pollack M, Montgomery S, Wessel T, Amato D, Krystal A, Hayduk R, McCall WV.
Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder [abstract]. Eur Psychiatry.
2008;
23(Suppl 2):S360.
Sackeim HA, Prudic J, Dillingham E, Isenberg K, Haskett R, McCall WV.
Do antideprssant [sic] medications enhance the efficacy of ECT: the Optimization of ECT study? [abstract]. Biol Psychiatry.
2008;
63(7 Suppl):41S-42S.
Fava M, McCall WV, Wessel T, Amato D, Paska W, Montgomery S, Roth T.
Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): a subgroup analysis [abstract]. Int J Neuropsychopharmacol.
2008;
11(Suppl 1):306.
Montgomery S, Fava M, Krystal A, Wessel T, Amato D, Cooper J, McCall WV.
Evaluation of the HAM-D17 following eszopiclone treatment in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder [abstract]. Int J Neuropsychopharmacol.
2008;
11(Suppl 1):306.
Quan SF, Berry RB, Buysse D, Collop NA, Grigg-Damberger M, Harding SM, Iber C, McCall WV, Sateia MJ, Sheldon SH, et al.
Development and results of the first ABMS subspecialty Certification Examination in Sleep Medicine. J Clin Sleep Med.
2008;
4(5):505-508.
Krystal A, Ancoli-Israel S, McCall W, Schaefer K, Claus R, Rubens R, Roth T.
The efficacy of 12 weeks of eszopiclone treatment in elderly patients with primary insomnia: effect on daytime function [abstract]. Eur Neuropsychopharmacol.
2008;
18(Suppl 4):S517.
Krystal A, Ancoli-Israel S, McCall W, Schaefer K, Claus R, Rubens R, Roth T.
A 12-week study of eszopiclone in elderly out-patients with primary insomnia: effects of treatment discontinuation [abstract]. Eur Neuropsychopharmacol.
2008;
18(Suppl 4):S517-S518.
Roth T, McCall W, Wessel T, Amato D, Paska W, Fava M.
Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): a subgroup analysis [abstract]. J Sleep Res.
2008;
17(Suppl 1):191-192.
Bech P, Krystal A, Walsh J, Rubens R, Caron J, Wessel T, Amato D, Roth T, McCall WV, Fava M.
Analysis of individual items of the Hamilton depression scale in a study of eszopiclone/fluoxetine co-therapy [abstract]. Eur Psychiatry.
2007;
22(Suppl 1):S224.
Haskett RF, Rosenquist PB, McCall WV, Isenberg K, Prudic J, Mulsant B, Sackeim HA.
The role of antidepressant medications during ECT: new findings from OPT-ECT [abstract]. J ECT.
2007;
23(1):56.
Montgomery S, Kinrys G, Krystal A, McCall WV, Roth T, Rubens R, Schaefer K, Roach J, Huang H, Krishnan R, et al.
Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia [abstract]. Eur Psychiatry.
2007;
22(Suppl 1):S238-S239.
Rosenquist PB, Kimball J, McCall WV.
Prediction of antidepressant response in both 2.25 X threshold RUL and fixed high dose RUL ECT [abstract]. J ECT.
2007;
23(1):55.
Fava M, Pollack M, Rubens R, Amato D, Krystal A, Hayduk R, McCall W.
Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder [abstract]. Sleep.
2007;
30(Abstr Suppl):A329-A330.
McCall W, Galla J, Dunn A, Boggs N, Kimball J, Rosenquist P.
Actigraphy measurement in depressed insomniacs [abstract]. Sleep.
2007;
30(Abstr Suppl):A342.
McCall W, Schaefer K, Rubens R, Huang H, Pfleeger K, Hayduk R, Roth T.
Effects of eszopiclone co-therapy with escitalopram on sleep outcomes in patients with insomnia and comorbid generalized anxiety disorder [abstract]. Sleep.
2007;
30(Abstr Suppl):A330.
Morin C, Schaefer K, Roach J, Pfleeger K, McCall W, Roth T.
Baseline sleep impairment as assessed by the insomnia severity index in patients with primary insomnia and insomnia co-morbid with psychiatric or other physical disorders [abstract]. Sleep.
2007;
30(Abstr Suppl):A245.
Rubens R, Wilson P, Schaefer K, McCall W, Roth T.
Changes in sleep outcomes with placebo treatment in patients with primary insomnia and insomnia co-morbid with peri-menopausal transition or rheumatoid arthritis [abstract]. Sleep.
2007;
30(Abstr Suppl):A247.
Amato D, McCall W, Roth T, Schaefer K, Rubens R, Wilson P, Walsh J.
A comparison of nightly and weekly patient reports of sleep by insomniacs using integrated voice response system (IVRS) [abstract]. Sleep.
2007;
30(Abstr Suppl):A344.
Fava M, Pollack M, Rubens R, Amato D, Krystal A, Hayduk R, McCall WV.
Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder [abstract]. Biol Psychiatry.
2007;
61(8 Suppl):84S.
Janicak PG, Nahas Z, Lisanby S, Solvason HB, Sampson S, McDonald W, Marangell L, Rosenquist P, McCall V, Kimball J, et al.
Durability of acute response to TMS in the treatment of major depression: relapse during a continuation pharmacotherapy extension study [abstract]. Biol Psychiatry.
2007;
61(8 Suppl):176S.
Rubens R, McCall WV, Wilson P, Schaefer K, Fava M, Pollack M, Roth T.
Changes in sleep outcomes with hypnotic placebo in patients with primary insomnia (PI) and insomnia co-morbid with major derpessive disorder (MDD) or generalized anxiety disorder (GAD) [abstract]. Biol Psychiatry.
2007;
61(8 Suppl):85S.
Schaefer K, McCall W, Krystal A, Rubens R, Wilson P, Pfleeger K, Roth T.
Relative effect sizes of eszopiclone treatment for insomnia in patients with primary insomnia and insomnia co-morbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis [abstract]. Sleep.
2007;
30(Abstr Suppl):A243-A244.
Solvason HB, Husain M, Fitzgerald PB, Rosenquist P, McCall V, Kimball J, Gilmer W, Lisanby S, Demitrack MA.
TMS in the acute treatment of major depression: improvements in functional status and quality of life [abstract]. Biol Psychiatry.
2007;
61(8 Suppl):263S.
Rosenquist PB, McCall WV.
Quality of life outcomes of ECT. In: Ritsner MS, Awad AG, eds. Quality of life impairment in schizophrenia, mood and anxiety disorders: new perspectives on research and treatment.
Dordrecht (The Netherlands): Springer;
2007:
321-331.
Pollack M, Kinrys G, Roth T, Rubens R, Schaefer K, Krystal A, McCall WV, Roach J, Huang H, Krishnan R.
Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia [abstract]. Neurology.
2007;
68(12 Suppl 1):A154.
Isenberg K, Haskett R, McCall V, Mulsant B, Prudic J, Hussain M, Pierce K, Sackeim H.
Concomitant antidepressant treatment during acute electroconvulsive therapy (ECT): enhanced response, low risk of adverse effects [abstract]. Int J Neuropsychopharmacol.
2006;
9(Suppl 1):S137.
Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.
Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia [abstract]. Neuropsychopharmacology.
2006;
31(Suppl 1):S173.
Bowler K, Rubens R, Wessel T, Caron J, Amato D, McCall WV, Fava M, Roth T.
Adjunctive eszopiclone and fluoxetine in major depressive disorder and insomnia: effects on sleep and depression [abstract]. Neurology.
2006;
66(5 Suppl 2):A78.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.